These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8248098)

  • 1. Strong inhibition of fibrinogen binding to platelet receptor alpha IIb beta 3 by RGD sequences installed into a presentation scaffold.
    Lee G; Chan W; Hurle MR; DesJarlais RL; Watson F; Sathe GM; Wetzel R
    Protein Eng; 1993 Sep; 6(7):745-54. PubMed ID: 8248098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
    Rahman S; Lu X; Kakkar VV; Authi KS
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential antagonism of the interactions of the integrin alpha IIb beta 3 with immobilized glycoprotein ligands by snake-venom RGD (Arg-Gly-Asp) proteins. Evidence supporting a functional role for the amino acid residues flanking the tripeptide RGD in determining the inhibitory properties of snake-venom RGD proteins.
    Lu X; Williams JA; Deadman JJ; Salmon GP; Kakkar VV; Wilkinson JM; Baruch D; Authi KS; Rahman S
    Biochem J; 1994 Dec; 304 ( Pt 3)(Pt 3):929-36. PubMed ID: 7529494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding interactions of kistrin with platelet glycoprotein IIb-IIIa: analysis by site-directed mutagenesis.
    Dennis MS; Carter P; Lazarus RA
    Proteins; 1993 Mar; 15(3):312-21. PubMed ID: 8456099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular model of RGD ligands. Antibody D gene segments that direct specificity for the integrin alpha IIb beta 3.
    Tomiyama Y; Brojer E; Ruggeri ZM; Shattil SJ; Smiltneck J; Gorski J; Kumar A; Kieber-Emmons T; Kunicki TJ
    J Biol Chem; 1992 Sep; 267(25):18085-92. PubMed ID: 1517241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic excision and in situ cyclization of a bioactive loop from an REI-VL presentation scaffold.
    Helms LR; Wetzel R
    Protein Sci; 1994 Jul; 3(7):1108-13. PubMed ID: 7920257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A paradigm for drug discovery using a conformation from the crystal structure of a presentation scaffold.
    Zhao B; Helms LR; DesJarlais RL; Abdel-Meguid SS; Wetzel R
    Nat Struct Biol; 1995 Dec; 2(12):1131-7. PubMed ID: 8846226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential recognition of snake venom proteins expressing specific Arg-Gly-Asp (RGD) sequence motifs by wild-type and variant integrin alphaIIbbeta3: further evidence for distinct sites of RGD ligand recognition exhibiting negative allostery.
    Rahman S; Flynn G; Aitken A; Patel Y; Hussain F; Lu X; Loftus JC; French D; Wijelath E; Strand K; Savidge GF
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):701-9. PubMed ID: 10642531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligands "activate" integrin alpha IIb beta 3 (platelet GPIIb-IIIa).
    Du XP; Plow EF; Frelinger AL; O'Toole TE; Loftus JC; Ginsberg MH
    Cell; 1991 May; 65(3):409-16. PubMed ID: 2018974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of ligand binding to glycoprotein IIb-IIIa (integrin alpha IIb beta 3) in isolated platelet membranes.
    Smyth SS; Parise LV
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):749-58. PubMed ID: 7686366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the RGD peptides and the gamma chain peptide of fibrinogen on fibrinogen binding to activated platelets.
    Mohri H; Ohkubo T
    Peptides; 1993; 14(2):353-7. PubMed ID: 8483813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic peptide with anti-platelet activity derived from a CDR of an anti-GPIIb-IIIa antibody.
    Jarrin A; Andrieux A; Chapel A; Buchou T; Marguerie G
    FEBS Lett; 1994 Nov; 354(2):169-72. PubMed ID: 7957919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic peptides demonstrate RGD-independent platelet glycoprotein IIb/IIIa recognition site in cell binding domain of human fibronectin.
    Mohri H; Tanabe J; Katoh K; Okubo T
    Peptides; 1995; 16(2):263-8. PubMed ID: 7784256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of the cross-linking sites of RGD and KQAGDV peptides to the isolated fibrinogen receptor, the human platelet integrin glycoprotein IIb/IIIa. Influence of peptide length.
    Calvete JJ; Schäfer W; Mann K; Henschen A; González-Rodríguez J
    Eur J Biochem; 1992 Jun; 206(3):759-65. PubMed ID: 1376688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet aggregation by grafting RGD and KGD sequences on the structural scaffold of small disulfide-rich proteins.
    Reiss S; Sieber M; Oberle V; Wentzel A; Spangenberg P; Claus R; Kolmar H; Lösche W
    Platelets; 2006 May; 17(3):153-7. PubMed ID: 16702041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An RGD to LDV motif conversion within the disintegrin kistrin generates an integrin antagonist that retains potency but exhibits altered receptor specificity. Evidence for a functional equivalence of acidic integrin-binding motifs.
    Tselepis VH; Green LJ; Humphries MJ
    J Biol Chem; 1997 Aug; 272(34):21341-8. PubMed ID: 9261147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen.
    Taub R; Gould RJ; Garsky VM; Ciccarone TM; Hoxie J; Friedman PA; Shattil SJ
    J Biol Chem; 1989 Jan; 264(1):259-65. PubMed ID: 2909518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of sulfur-free cyclic hexapeptides which contain the RGD sequence and bind to the fibrinogen GP IIb/IIIa receptor. A conformation-based correlation between propensity for imide formation and receptor affinity.
    Lender A; Yao W; Sprengeler PA; Spanevello RA; Furst GT; Hirschmann R; Smith AB
    Int J Pept Protein Res; 1993 Dec; 42(6):509-17. PubMed ID: 8307682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics simulations of certain RGD-based peptides from Kistrin provide insight into the higher activity of REI-RGD34 protein at higher temperature.
    Upadhyay SK
    Chem Biol Drug Des; 2014 May; 83(5):600-9. PubMed ID: 24877256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hybrid peptide analogs to receptor recognition domains on alpha- and gamma-chains of human fibrinogen on fibrinogen binding to platelets.
    Mohri H; Ohkubo T
    Thromb Haemost; 1993 May; 69(5):490-5. PubMed ID: 8322271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.